GREEN TEAMS Engaging Employees in Sustainability By Deborah Fleischer President Green Impact GreenBiz Reports ® GREEN TEAMS: Engaging Employees in Sustainability BY DEBORAH FLEISCHER November 2009 Helping companies go green Sustainability Strategy Employee Engagement Program Development Communications 390 Throckmorton · Mill Valley‚ CA 94941 · (415) 302-2655 www.GreenImpact.com www.GreenImpact.com GREEN TEAMS: Engaging Employees in Sustainability
Premium Sustainability Recycling
| 2013 | | SDM IMD | [SSLM Group Assignment: Hindalco Industries] | Submitted By Karan Dave Abhishek Pal Rishi Gandhi Sourdeep Basu Vamsi Krishna Harsh Singh Submitted By Karan Dave Abhishek Pal Rishi Gandhi Sourdeep Basu Vamsi Krishna Harsh Singh | Contents Introduction 1 History 1 HINDALCO & ITS SUBSIDIARIES/JVs 2 Products & services offered 2 Key Financials 3 Awards and Significant Achievements 5 Stock movement during the span of 2000-2013 7
Premium Aditya Birla Group Aluminium Electrolysis
XenoMouse: Produces antibodies for disease targets Benefits: Longer therapy‚ fewer side effects‚ faster drug development Abgenix & the Xenomouse 1 Case Questions • Which of the three alternatives would you recommend to the company? 1. A Pharmacol “hand-off” deal (who is Pharmacol)? 2. A Biopart “hand-in” deal (who is Biopart)? 3. “Go-it-alone” through Phase II & then decide a development strategy? • What are the direct financial implications of your answer? • What are the strategic
Premium Clinical trial
VentureNavigator Facebook Login | Sign Up | Login Home Assessment Resources Community About Contact Resources Not Rated A Recent History Of The Pharmaceutical Industry - Based On All Five Forces August 2007 (The New Business Road Test) ProductionIntellectual PropertyCompetitionMarketsBusiness ModelPorters 5 Forces. Similar Articles: Going Digital: A Sound Guide for Songwriters and Musicians T-Shirts
Premium Pharmacology Pharmaceutical industry Drug development
created the first transgenic organism. He combined one bacterium with a virus and then injected that virus into an E. coli bacterium. This method is similar to the retrovirus-mediated gene transfer. Boyer then went on to create the Genentech in 1976. A year later Genentech used this technology to create a bacteria that produced insulin. In 1974 the first transgenic animal‚ a mouse‚ was created. Since then many companies have been using transgenesis to create unique products with desirable qualities
Premium Genetically modified organism
HBR Spotlight How to Manage the Most Talented How do you manage people who don’t want to be led and may be smarter than you? CLEVER PEOPLE by Rob Goffee and Gareth Jones LEADING F ranz Humer‚ the CEO and chairman of the Swiss pharma- ceutical giant Roche‚ knows how difficult it is to find good ideas. “In my business of research‚ economies of scale don’t exist‚” he says.“Globally today we spend $4 billion on R&D every year. In research there aren’t economies of scale‚ there are
Premium
(external) 1999 Albert Gore‚ Jr. Former Vice President of the United States (external) 2003 Andrea Jung Chairman and Chief Executive Officer Avon Products‚ Inc. (external) 2008 Arthur D. Levinson‚ Ph.D. Chairman and Chief Executive Officer Genentech‚ Inc. (external) 1980 Ronald D. Sugar‚ Ph.D. Former Chairman and CEO Northrop Grumman Corporation (external) 2010 2. Members of the board do in fact own stock in Apple including Tim Cook who was given 1 million shares when he became CEO
Premium Corporate governance Board of directors Corporate title
brought into the corporate world by influential executives‚ CIOs rethinking their approach to deploying technology‚ and younger workers who move seamlessly between their personal and business lives.There are several high-profile businesses‚ such as Genentech and Disney (both with strong ties to Apple CEO Steve Jobs‚ of course)‚ that have declared their intentions to work with Apple on deploying iPhones inside their corporations. That seems to be having the effect of increasing the overall number of business
Premium Steve Jobs Smartphone Apple Inc.
Q3. What are the prospects for the industry going forward? 1.Though the average level of profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect
Premium Pharmaceutical industry Pharmacology Generic drug
You’ve probably watched the TV series from the creator of legendary superheroes‚ Stan Lee‚ seeking out real life superhumans - people whose remarkable powers stem from being genetically different. Imagine not being able to feel any pain or having bones so strong that they are nearly unbreakable. Superhumans walk among us and can do things that have scientists scratching their heads. These “off the curve individuals” are setting new parameters. Isaac Asimov‚ the famous thinker and sci-fi writer
Premium DNA Genetics Gene